Seizure of Potentially Dangerous Products at Ontario's The Love Shop
(firmenpresse) - OTTAWA, ONTARIO -- (Marketwire) -- 02/23/12 -- The issue:
Health Canada seized a variety of Stiff4Ever and PurePillz products from The Love Shop retail outlets located in Ontario. These products are unauthorized drugs and are considered potentially dangerous to the health and safety of Canadians.
Health Canada tested the Stiff4Ever products, advertised as male sexual stimulants, and identified undeclared prescription medications in the products. The labels of the PurePillz products (see below) state that they contain BZP and TFMPP. Health Canada is considering the addition of BZP and TFMPP to Schedule III to the Controlled Drugs and Substances Act and the Schedule to Part J of the Food and Drug Regulations.
Who is affected:
Canadians who have purchased any of the PurePillz products or the "Stiff4Ever" products. Pregnant or nursing women and children, individuals taking any nitrate drug (e.g. nitroglycerine) and those with a history of heart problems or stroke may be at increased risk.
What consumers should do:
What Health Canada is doing:
Health Canada has requested that The Love Shop stop distributing unauthorized health products to their retail stores and recall these potentially dangerous products from the Canadian market.
Background:
Stiff4Ever:
Sildenafil is a prescription medication that should only be used under the supervision of a health care practitioner. Products containing sildenafil should never be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems including high blood pressure, a history of heart attack, stroke, abnormal heart beat or chest pain are at higher risk of cardio-vascular side effects if they engage in sexual activity, including if they use sildenafil to help them achieve an erection. Other possible side-effects of using sildenafil include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.
The risk of serious complications requires that yohimbine, a prescription drug, should only be taken under the supervision of a health care practitioner. Yohimbine should not be used by pregnant or nursing women, or children.
As of today, Health Canada has not received any adverse reactions reports associated with the use of these products.
PurePillz:
Benzylpiperazine (BZP) is a synthetic substance with stimulant-like effects, while 3-trifluoromethylphenylpiperazine (TFMPP) is a synthetic substance with hallucinogen-like effects. BZP and 3-TFMPP have no known therapeutic use. While BZP is frequently claimed to be a "natural" substance, it is a synthetic substance. These substances may cause adverse effects such as increased body temperature, increased blood pressure and heart rate, abnormal heart rhythm, nausea, vomiting, and kidney damage.
Other reported adverse effects include confusion, agitation, anxiety, hallucinations, paranoia, seizures, and convulsions. These substances could also negatively interact with other substances, such as alcohol and prescription drugs. As such, ingestion of BZP and/or TFMPP, alone or with other drugs, poses a significant health risk to users. Scientific data also indicates that BZP has abuse potential because of its amphetamine-like effects. The long-term side effects of using BZP and/or TFMPP are unknown. Health Canada advises Canadians to avoid products with these substances.
For more information:
Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.
Media enquiries related to this Advisory should be directed to Health Canada Media Relations at 613-957-2983.
How to report side effects to health products:
To report suspected adverse reaction to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a () and send to us using one of these methods:
Related Health Canada Web content:
-- Advisory (July 6, 2011): ()
-- Advisory (July 4, 2011): Canadians ()
-- Advisory (June 14, 2011): ()
-- Advisory (July 13, 2010): ()
-- Advisory (March 8, 2010): ()
-- Advisory (January 8, 2010) - ()
-- Advisory (December 24, 2009) - ()
-- Advisory (July 10, 2008) - ()
Stay connected with Health Canada and receive the latest advisories and product recalls using these social media tools:
Images of the products are available at the following address:
Egalement disponible en francais
Contacts:
Media Inquiries:
Health Canada
613-957-2983
Public Inquiries:
613-957-2991
1-866-225-0709
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 23.02.2012 - 13:34 Uhr
Sprache: Deutsch
News-ID 1086301
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
OTTAWA, ONTARIO
Phone:
Kategorie:
Government & Administration
Anmerkungen:
Diese Pressemitteilung wurde bisher 86 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Seizure of Potentially Dangerous Products at Ontario's The Love Shop
"
steht unter der journalistisch-redaktionellen Verantwortung von
Health Canada (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
